INS and diabetes mellitus: Combined with their independence from external assistance during drug delivery, there are reasons to believe that anchored drug delivery microrobots have greater prospects for the treatment of diabetes with oral insulin or other macromolecular drugs compared to other types of oral delivery microrobots.